NCT00454272View on ClinicalTrials.gov

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
InfectionFebrile Neutropenia
Interventions
DRUG

Teicoplanin

DRUG

Vancomycin

Trial Locations (1)

Unknown

Sanofi aventis administrative office, Istanbul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY